State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Hidradenitis Suppurativa (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)Pressure Injury (2)Cardiovascular Diseases (2)Overweight (2)Obesity (2)
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04797286 Phase 2
Recruiting
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Condition
Scleroderma
Enrollment
30 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05648214 Phase 1
Recruiting
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adu...
Condition
Healthy Volunteers
Enrollment
156 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT06933472 Phase 3
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosp...
Condition
Hyperphosphatemia
Enrollment
264 pts
Location
United States, China
Sponsor
Alebund Pharmaceuticals
NCT07404865 Phase 3
Recruiting
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Condition
Primary Sjogren's Disease
Enrollment
250 pts
Location
United States
Sponsor
Vor Biopharma
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT06976112 N/A
Recruiting
Impact of Lean Pork on Endothelial Function in Perimenopause
Condition
Cardiovascular Outcome
Enrollment
30 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07374107 N/A
Recruiting
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Condition
IBM
Enrollment
700 pts
Location
United States
Sponsor
Myositis International Health
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
NCT04228978 N/A
Recruiting
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...
Condition
Peripheral Artery Disease
Enrollment
212 pts
Location
United States
Sponsor
Northwestern University
NCT06263426 N/A
Recruiting
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term O...
Condition
Hiv
Enrollment
200 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
NCT06070350 Phase 3
Recruiting
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage...
Condition
Hemorrhagic Shock
Enrollment
1,000 pts
Location
United States
Sponsor
Philip Spinella
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07047716 Phase 3
Recruiting
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis...
Condition
HIV Pre-exposure Prophylaxis
Enrollment
350 pts
Location
United States
Sponsor
Gilead Sciences
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
NCT04858776 Phase 2
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thro...
Condition
Iliofemoral; Thrombosis
Enrollment
60 pts
Location
United States, Ireland, United Kingdom
Sponsor
Mercator MedSystems, Inc.
NCT03890861 N/A
Recruiting
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
Condition
Dementia, Alzheimer Type
Enrollment
125 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT07280260 Phase 4
Recruiting
Clinical Performance of Nobel N1 System
Condition
Tooth Loss
Enrollment
50 pts
Location
United States
Sponsor
Louisiana State University Hea
NCT06297291 N/A
Recruiting
Global Paradise System US Post Approval Study
Condition
Hypertension
Enrollment
1,000 pts
Location
United States
Sponsor
ReCor Medical, Inc.
NCT07023185 N/A
Recruiting
Cold and Compression Post TKA
Condition
Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery
Enrollment
90 pts
Location
United States
Sponsor
Ochsner Health System